| A phase 2 trial of sibeprenlimab in patients with IgA nephropathy M Mathur, J Barratt, B Chacko, TM Chan, L Kooienga, KH Oh, M Sahay, ... New England Journal of Medicine 390 (1), 20-31, 2024 | 29 | 2024 |
| Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation GVR Prasad, J Beckley, M Mathur, M Gunasekaran, MM Nash, L Rapi, ... BMC infectious diseases 19, 1-7, 2019 | 27 | 2019 |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of VIS649 (sibeprenlimab), an APRIL-neutralizing IgG2 monoclonal antibody, in healthy volunteers M Mathur, J Barratt, Y Suzuki, F Engler, MF Pasetti, J Yarbrough, S Sloan, ... Kidney International Reports 7 (5), 993-1003, 2022 | 23 | 2022 |
| A clinicopathologic study of glomerular disease: A single-center, five-year retrospective study from Northwest India P Beniwal, L Pursnani, S Sharma, RK Garsa, M Mathur, P Dharmendra, ... Saudi Journal of Kidney Diseases and Transplantation 27 (5), 997-1005, 2016 | 19 | 2016 |
| Incidence and profile of C3 Glomerulopathy: A single center study M Mathur, S Sharma, D Prasad, R Garsa, AP Singh, R Kumar, P Beniwal, ... Indian Journal of Nephrology 25 (1), 8-11, 2015 | 19 | 2015 |
| The incidence and prevalence of IgA nephropathy in Europe CJ Willey, R Coppo, F Schaefer, M Mizerska-Wasiak, M Mathur, ... Nephrology Dialysis Transplantation 38 (10), 2340-2349, 2023 | 18 | 2023 |
| A comparative study of central versus posterior approach for internal jugular hemodialysis catheter insertion M Mathur, AVL D'Souza, D Prasad, R Garsa, N Bansal, R Jhorawat, ... Indian Journal of Nephrology 25 (5), 265-268, 2015 | 9 | 2015 |
| MO258 Safety, tolerability, pharmacokinetics and pharmacodynamics of VIS649, an APRIL-neutralizing IgG2 monoclonal antibody, in healthy volunteers: Phase 1, randomized, double … Y Suzuki, M Mathur, J Barratt, F Engler, J Yarbrough, S Sloan, D Oldach Nephrology Dialysis Transplantation 36 (Supplement_1), gfab104. 0016, 2021 | 8 | 2021 |
| Uremic frost M Mathur, AVL D'Souza, V Malhotra, D Agarwal, P Beniwal Clinical kidney journal 7 (4), 418-419, 2014 | 8 | 2014 |
| Fanconi syndrome due to light chain proximal tubulopathy in a patient with multiple myeloma M Mathur, B Chacko, M Vankalakunti, C Patil Saudi Journal of Kidney Diseases and Transplantation 27 (4), 805-807, 2016 | 5 | 2016 |
| Effect of renal transplantation on multiple hormone levels in patients of chronic kidney disease: A single center study R Kumar, R Jhorawat, M Mathur, RK Garsa, PD Kimmatkar, S Sharma, ... indian journal of transplantation 8 (3), 75-79, 2014 | 5 | 2014 |
| A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence M Mathur, TM Chan, KH Oh, L Kooienga, M Zhuo, CS Pinto, B Chacko Journal of clinical medicine 12 (21), 6927, 2023 | 4 | 2023 |
| # 3347 COVID vaccine responses during sibeprenlimab treatment of IgA nephropathy (IgAN): An interim analysis K Mccafferty, K Follman, M Pasetti, A Schachter, M Mathur, D MA, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063a_3347, 2023 | 4 | 2023 |
| Global incidence of IgA nephropathy by race and ethnicity: a systematic review K Kiryluk, DE Freedberg, J Radhakrishnan, L Segall, JS Jacobson, ... Kidney360 4 (8), 1112-1122, 2023 | 3 | 2023 |
| Are we Treating or Curing Tuberculosis? Profile of Secondary Renal Amyloidosis in Patients Receiving Anti Tubercular Treatment S Sharma, M Mathur, D Prasad, AP Singh, R Garsa, R Kumar, P Beniwal, ... BANTAO Journal 12 (2), 103-107, 2014 | 3 | 2014 |
| WCN23-0684 Interim biomarker analysis from a randomized, double-blind, placebo-controlled, phase 2 trial of sibeprenlimab (VIS649) in participants with immunoglobulin A nephropathy DTM Chan, T Kanjanabuch, A Liew, M Mathur, J Yarbrough, X Wang, ... Kidney International Reports 8 (3), S76-S77, 2023 | 2 | 2023 |
| The use of CT angiography in the evaluation of living donors for kidney transplantation P Beniwal, S Pandey, RK Garsa, M Mathur, V Malhotra, D Agarwal Indian Journal of Transplantation 8 (2), 39-43, 2014 | 2 | 2014 |
| Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants X Zhang, Y Wang, J Yarbrough, M Mathur, L Andrews, B Pereira, ... Clinical Pharmacology in Drug Development 12 (12), 1211-1220, 2023 | 1 | 2023 |
| Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development S Pregizer, T Vreven, M Mathur, LN Robinson Frontiers in Molecular Biosciences 10, 1176856, 2023 | 1 | 2023 |
| THE ASSOCIATION BETWEEN SURROGATE KIDNEY ENDPOINTS AND HARD CLINICAL OUTCOMES IN IGA NEPHROPATHY: A SYSTEMATIC LITERATURE REVIEW M Lorenzi, SN Ali, D Makhija, S Ebohon, T Olodapo, V Diaby, M Mathur, ... AMERICAN JOURNAL OF KIDNEY DISEASES 81 (4), S89-S89, 2023 | 1 | 2023 |
